News – Page 968 – Endpoints News

A stem cell therapy preps debut in Japanese market to the dismay of US researchers

7 years ago

AbbVie shares slide on sliding Humira revenue; Deerfield is making a big investment in new device startups

7 years ago

GSK, Sanofi enlist in a big genomics project aiming to map genes of half a million Finns

7 years ago

Vertex COO Ian Smith ousted due to 'personal behavior'; CFO Mats Blom exits Zealand Pharma; Katrine Bosley abruptly ...

7 years ago

The antibiotics R&D effort is broken. Here's one market solution that might fix it

7 years ago

Global funding for neglected disease R&D hit record high in 2017 — with meaty contributions by UK, EC, India and ...

7 years ago

In another setback for Eli Lilly, FDA follows EMA in calling for a halt to new Lartruvo prescriptions

7 years ago

UK looks to ensure pharma submissions can continue under no deal Brexit

7 years ago

FDA opioid adcomm chair blasts agency for 'willful blindness that borders on the criminal'

7 years ago

Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech

7 years ago

Rituxan copycat passes first pivotal test for Amgen, Allergan; Ironwood and biotech spinout name new boards

7 years ago

Vertex sharpens focus on gene-editing in licensing deal with Merck KGaA

7 years ago

Mass cloning for neuro research? Chinese scientists report birth of five gene-edited monkeys

7 years ago

After kickback from the FDA, Bristol-Myers yanks its Opdivo/Yervoy BLA for high TMB approach to lung cancer

7 years ago

Shutdown thrusts Gossamer Bio onto a rarely used path for fixed-price IPO

7 years ago

Vertex ousts longtime exec Ian Smith over unspecified code of conduct violations

7 years ago

What’s up with all the buzz about Gilead’s PhIII NASH drug selonsertib?

7 years ago

FDA forces troubled Advaxis to halt enrollment on its PhIII study for lead drug axalimogene

7 years ago

Turning the table on CD47, Penn team primes macrophages to ignore 'don't eat me' signal

7 years ago

EMA wants docs to stop prescribing Eli Lilly’s cancer drug Lartruvo — and here's why

7 years ago

Microbiome test maker uBiome cuts 55 jobs to sharpen focus on drugs, partnerships — CNBC

7 years ago

RNAi leader Alnylam inks collaboration pact with startup; GV's Rosana Kapeller joins Schrödinger board

7 years ago

KKR backs monster $300M raise to build up a new-model biotech — designed by Neil Kumar and MIT’s Andrew Lo

7 years ago

BioNTech doubles down on an antibody discovery group, scooping up a new team to play for the mRNA specialist

7 years ago

First page Previous page 965 966 967968969 970 971 Next page Last page